Pharma-Bio Serv (PBSV) Operating Income (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Operating Income came in at $144676.0 in Q2 2026, up 247.15% on a YoY basis from $41675.9 in Q2 2025, and up 253.04% quarter-over-quarter from -$94535.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Operating Income (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Operating Income for 16 consecutive years, with $144676.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Income rose 247.15% year-over-year to $144676.0; the trailing twelve-month figure through Apr 2026 stood at -$397008.0 (up 45.35% YoY), and the FY2025 full-year result was -$637662.0, up 50.48% from the prior year.
- Operating Income climbed to $144676.0 in Q2 2026 per PBSV's latest filing, from -$94535.0 in the prior quarter.
- Across five years, Operating Income topped out at $460466.0 in Q3 2023 and bottomed at -$438300.0 in Q1 2024.
- Historically, Operating Income has averaged $23180.4 across 5 years, with a median of -$71978.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Operating Income plunged 233.37% in 2024, then jumped 247.15% in 2026.
- Over 5 years, Operating Income stood at $168962.0 in 2022, then slumped by 130.64% to -$51765.0 in 2023, then tumbled by 197.75% to -$154130.0 in 2024, then gained by 13.53% to -$133272.0 in 2025, then jumped by 208.56% to $144676.0 in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $144676.0, -$94535.0, and -$133272.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 3.18 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 150.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 378.52 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 157.93 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 279.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 192.94 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 101.52 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 85.02 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 58.15 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 144,676.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 144,676.00 |
| Jan 31, 2026 | -94,535.00 |
| Oct 31, 2025 | -133,272.00 |
| Jul 31, 2025 | -313,877.00 |
| Apr 30, 2025 | -98,322.00 |
| Jan 31, 2025 | -92,191.00 |
| Oct 31, 2024 | -154,130.00 |
| Jul 31, 2024 | -381,782.00 |
| Apr 30, 2024 | -313,375.00 |
| Jan 31, 2024 | -438,300.00 |
| Oct 31, 2023 | -51,765.00 |
| Jul 31, 2023 | 460,466.00 |
| Apr 30, 2023 | 380,078.00 |
| Jan 31, 2023 | 328,632.00 |
| Oct 31, 2022 | 168,962.00 |
| Jul 31, 2022 | 369,505.00 |
| Apr 30, 2022 | 280,630.00 |
| Jan 31, 2022 | 355,848.00 |
| Oct 31, 2021 | -4.80 Mn |
| Jul 31, 2021 | 360,490.00 |